Routus AC Tablet

Routus AC Tablet is used for prevention of heart attack. It is a combination of medicines that prevent clot formation in the blood vessels. It also helps to reduce increased cholesterol and triglycerides levels.

Routus AC Tablet is used for prevention of heart attack. It is a combination of medicines that prevents clot formation in the blood vessels. It also helps to reduce increased cholesterol and triglycerides levels. This medicine should be taken with food regularly at a fixed time each day. This medicine should not be stopped abruptly and taken strictly as advised by the doctor. Lifestyle changes like low-fat diet, exercise, and not smoking may help this medicine work better. This medicine increases your risk of bleeding, so it is important to be careful while shaving, cutting nails, and using sharp objects. Few common side effects of this medicine may include stomach pain, indigestion, diarrhea, and muscle pain.

• Heart attack

Heart attack
Routus AC Tablet is a combination medicine that is used to prevent heart attack. It contains Rosuvastatin that works by reducing the amount of “bad” cholesterol (LDL) and raising the amount of “good” cholesterol (HDL) in your blood. High levels of cholesterol can cause your blood vessels to narrow (atherosclerosis). Lowering the amount of cholesterol reduces the chances of heart diseases and helps you remain healthier for longer.
Besides, it also contains two blood thinners, Aspirin and Clopidogrel, that together prevent the formation of blood clots and also prevent the existing ones from growing bigger in size. Take it regularly and make appropriate lifestyle changes (such as eating healthy and staying active) to maximize the effectiveness of this medicine. Keep taking it even if you feel well.

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Common side effects of Rosuson Gold

• Increased bleeding tendency
• Abdominal pain
• Indigestion
• Bruise
• Nosebleeds
• Gastrointestinal bleeding
• Weakness
• Headache
• Muscle pain
• Diarrhea
• Nausea

Take this medicine in the dose and duration as advised by your doctor. Routus AC Tablet is to be taken with food.

Routus AC Tablet is a combination of three medicines: Aspirin, Rosuvastatin and Clopidogrel, which prevents heart attack. Aspirin and clopidogrel are antiplatelet medications. They work by preventing the platelets from sticking together and decrease the formation of harmful blood clots. Rosuvastatin is a lipid lowering medication that blocks the body’s ability to produce “bad” cholesterol (LDL) and improves the level of "good" cholesterol (HDL).

• You have been prescribed Routus AC Tablet to lower your risk of heart attacks and stroke.

• Take it with food to avoid an upset stomach.

• It increases your risk of bleeding. Be careful while shaving, cutting fingernails or toenails, or using sharp objects.

• Notify your doctor if you are more tired than usual, do not feel hungry, or if you have yellow eyes, skin.

• Notify your doctor if you experience muscle symptoms (pain or weakness), particularly if you have fever, a sick feeling or dark urine.

• Let your doctor know you are taking Routus AC Tablet before undergoing any surgical procedure.

• Let your doctor know if you are pregnant or planning for pregnancy.

[CiplaMed. Rosuvastatin Calcium + Aspirin. Accessed 12 Apr. 2019 (online) Available from:

Aspirin. Maidenhead, Berkshire: Intrapharm Laboratories Limited; 2011 [revised 14 Jan. 2018]. [Accessed 12 Apr. 2019] (online) Available from:

Rosuvastatin calcium. Carolina, Puerto Rico: IPR Pharmaceuticals, Inc.; 2003. [Accecssed 11 Apr. 2019] (online) Available from:

Clopidogrel hydrogen sulfate. North Harrow, Middlesex; Accord Healthcare Limited; 2010 [revised 05 Jun. 2018]. [Accessed 12 Apr. 2019] (online) Available from:

NHS. Low-dose aspirin. [Accessed 11 Apr. 2019] (online) Available from:

ScienceDirect. Rosuvastatin. [Accessed 12 Apr. 2019] (online) Available from:

Clopidogrel bisulfate. New York, New York: Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership; 2006. [Accessed 12 Apr. 2019] (online) Available from: